IL10 and rheumatoid arthritis: By the end of the study, significant differences were observed between the probiotic and placebo groups in IL-10/IL-12 (p = 0.038) and IL-10/total Th1 (p = 0.006), suggesting an improved inflammatory profile in RA patients.